肺癌SABR中MLC追踪减少PTV体积并保护危及器官
本研究对10例曾接受基于ITV计划治疗的肺癌SABR患者,重新制定MLC追踪与midV计划,并在运动模体上模拟真实肺运动实施照射,于计划扫描中重建递送剂量。结果显示MLC追踪和midV较ITV计划PTV体积平均减少33.9%和22%,MLC追踪的GTV覆盖更优且危及器官剂量降低更多。
要点
- MLC追踪与midV计划较ITV计划分别平均减少PTV体积33.9%和22%。
- MLC追踪的GTV剂量覆盖优于midV和ITV计划。
- MLC追踪降低肺、食管、大血管、气管、心脏和脊髓的剂量。
核心结论
- MLC追踪较midV和ITV计划减少PTV体积、改善GTV剂量覆盖并更好地保护危及器官。
研究设计与样本
- 对10例原接受ITV计划治疗的肺癌SABR患者重新制定MLC追踪与midV计划。
- 所有计划在直线加速器上对运动模体以真实肺运动模拟治疗实施,并在患者计划扫描中重建递送剂量。
主要发现
- MLC追踪与midV计划较ITV计划平均减少PTV体积分别为33.9%和22%。
- MLC追踪的GTV剂量覆盖优于midV和ITV计划。
- MLC追踪较ITV计划降低肺平均剂量0.8Gy、食管D3cc 1.9Gy、大血管D10cc 3.2Gy、气管D4cc 1.1Gy、心脏D1cc 2.0Gy、脊髓D0.03cc 0.5Gy。
- midV较ITV计划降低肺平均剂量0.2Gy、食管D3cc 1.4Gy、大血管D10cc 1.3Gy、气管D4cc 0.9Gy、心脏D1cc 0.5Gy,脊髓D0.03cc增加0.1Gy。
临床怎么用
- 肺癌SABR可采用MLC追踪以缩小PTV体积并降低危及器官剂量。
局限性
- 研究基于10例患者计划在运动模体上的模拟实施与剂量重建,非临床患者实际治疗验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Assess the dosimetric impact of multi-leaf collimator (MLC) tracking and mid-ventilation (midV) planning compared with the internal target volume (ITV)-based planning approach for lung Stereotactic Ablative Body Radiotherapy (SABR). METHOD: Ten lung SABR patients originally treated with an ITV-based plan were re-planned according to MLC tracking and midV planning schemes. All plans were delivered on a linac to a motion phantom in a simulated treatment with real lung motions. Delivered dose was reconstructed in patient planning scans. ITV-based, tracking and midV regimes were compared at the planning and delivered stages based on PTV volume and dose metrics for the GTV and OAR. RESULTS: MLC tracking and midV schemes yielded favourable outcomes compared with ITV-based plans. Average reduction in PTV volume was (MLC tracking/MidV) 33.9%/22%. GTV dose coverage performed better with MLC tracking than the other regimes. Reduction in dose to OAR were for the lung (mean lung dose, 0.8Gy/0.2Gy), oesophagus (D3cc, 1.9Gy/1.4Gy), great vessels (D10cc, 3.2Gy/1.3Gy), trachea (D4cc, 1.1Gy/0.9Gy), heart (D1cc, 2.0Gy/0.5Gy) and spinal cord (D0.03cc, 0.5Gy/-0.1Gy). CONCLUSION: MLC tracking showed reduction in PTV volume, superior GTV dose coverage and organ dose sparing than MidV and ITV-based strategies.
引用
- Caillet V, Keall PJ, Colvill E, et al. MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk. Radiother Oncol. 2017. PMID: 28655454. doi:10.1016/j.radonc.2017.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。